01:54 PM EDT, 07/30/2024 (MT Newswires) -- Vivos Therapeutics ( VVOS ) filed a registration statement Tuesday for the sale of common stock, pre-funded warrant, and share purchase warrant by a selling shareholder.

The statement covers the sale of 169,498 shares, pre-funded warrant to buy over 3 million common shares in the company, and purchase warrant to buy up to another 3.2 common stock.

Vivos said it would not receive any proceeds from the sale of the securities which were issued as part of a private placement in June.

Vivos said the proceeds would go to V-CO Investors, the selling stockholder, who is an affiliate of private equity firm Seneca which took part in the private placement.

Price: 2.32, Change: +0.03, Percent Change: +1.31